It's All About/Charitable Organization/Lexington/Finding Cure For T1 D
The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services List of Video Credits can be found here http://broadcaster.beazil.net/public/credits/youtube/videos/41619 When you are in the Horse Capital of the World or Lexington, be sure to stop by and see us at our downtown Visitor Center, 401 West Main Street, in The Square. Look for the awning with the famous blue horse, Big Lex. We are open Monday through Friday from 9:00 a.m. to 5 p.m., and Saturdays from 10 a.m. to 5 p.m. (Open Sunday afternoons from noon till 5 p.m. in the summer.) Speak with a Visitor Information Specialist, browse our informative brochures and maps, watch videos about the Bluegrass Region on one of five interactive screens and check out our Bourbon still and other memorabilia. For now, doctors don’t know the exact reason that lead to T1D, but they do know that your genes play a role. They also know that Type 1 Diabetes can result when something in the environment, like a virus, tells your immune system to go after your pancreas. Most of people with T1D have signs of this attack, called autoantibodies. They are presented in almost everyone who has the condition when their blood sugar is high. Type 1 diabetes can happen along with other autoimmune diseases, like Grave’s disease or vitiligo. The symptoms are often subtle, but can become severe. JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It seems important to mention the main issues –
donate to help,insulin pumps,SDP,diabetes management,ACCORD Study,show your support,ketosis,hyperglycemic crisis,Novolin R,Blood Glucose Level,A1C,Political advocacy,injectable long-acting insulin,six international affiliates,volunteering,DonorDrive,Insulin injections,Insulin Nation,Scientific,Top Research Highlights,T1D Triggers,Managing a hypo,Ketoacidosis,make a donation,Random Plasma Glucose Test,children diabetes,DPP-4 inhibitors,join our community,research,The Kumamoto Study,Government Advocacy,Diabetes Research,patient self-monitoring of blood glucose,cure therapies,fundraising,preventive therapies,Humulin R,beta cells release insulin,T1D,First time with insulin pump,low-density lipoprotein cholesterol,TrialNet,blindness,TypeOnesie,World without T1D,make a contribution,T1D community,Regular Acting Insulin,b-cell destruction,Online Diabetes Support Team,plasma glucose criteria,Glucagon,Education,diabetic myelopathy,HAPO Study,IGT,ketone,Jump to cure Diabetes,diabetic retinopathy,Research Grants,transplantation insulin-secreting cells,Bag of Hope,Type 1 Diabetes Dictionary,treatment,get support,diabetes care,support our research,Dymelor,assessment of glycemic control,Research funding,Traveling with Diabetes,NRTIs,Celiac Disease and Diabetes,worldwide effort,hyperglycemia,At Risk,Accredited Charity,Parents of children with T1D,JDRF lobbies,insulin pen,biguanide,inhaled insulin,permanent insulinopenia,IGT,Cure research,patient-driven care,Levemir,donate today,Team Cure Diabetes,Diabetic Eye Complications,Heart Disease,Beta Cell Health and Survival,donate to.